Academic drug discovery: current status and prospects

Area of Science:

• Drug Discovery
• Medicinal Chemistry
• Pharmacology

Background:

• Pharmaceutical drug discovery has contracted, leading to a rise in academic drug discovery groups.
• Increased collaboration between pharmaceutical companies and academic institutions marks a new era in drug discovery.
• Academic groups are increasingly vital in the drug discovery landscape.

Purpose of the Study:

• To review the current status of academic drug discovery groups.
• To outline their achievements and challenges.
• To provide perspectives for improving drug discovery outcomes.

Main Methods:

• Literature review of academic drug discovery.
• Analysis of achievements and challenges faced by academic groups.
• Synthesis of expert opinions on future directions.

Main Results:

• Academic groups have historically contributed significantly to drug discovery.
• Modern drug discovery is complex with high failure rates due to poorly understood human biology.
• Academic groups need to leverage their strengths and learn from industry experiences.

Conclusions:

• Academic drug discovery groups play a crucial role.
• Key areas for improvement include target validation and high throughput screening (HTS) hit accuracy.
• Enhancing molecular probe quality and investing in informatics infrastructure are essential for success.